JP2004536857A5 - - Google Patents

Download PDF

Info

Publication number
JP2004536857A5
JP2004536857A5 JP2003513564A JP2003513564A JP2004536857A5 JP 2004536857 A5 JP2004536857 A5 JP 2004536857A5 JP 2003513564 A JP2003513564 A JP 2003513564A JP 2003513564 A JP2003513564 A JP 2003513564A JP 2004536857 A5 JP2004536857 A5 JP 2004536857A5
Authority
JP
Japan
Prior art keywords
oil
group
use according
composition
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003513564A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004536857A (ja
Filing date
Publication date
Priority claimed from AUPR6443A external-priority patent/AUPR644301A0/en
Application filed filed Critical
Publication of JP2004536857A publication Critical patent/JP2004536857A/ja
Publication of JP2004536857A5 publication Critical patent/JP2004536857A5/ja
Withdrawn legal-status Critical Current

Links

JP2003513564A 2001-07-17 2002-07-16 癌の治療のための方法及び組成物 Withdrawn JP2004536857A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR6443A AUPR644301A0 (en) 2001-07-17 2001-07-17 Method and composition for treatment of cancer
PCT/AU2002/000954 WO2003007957A1 (en) 2001-07-17 2002-07-16 Method and composition for treatment of cancer

Publications (2)

Publication Number Publication Date
JP2004536857A JP2004536857A (ja) 2004-12-09
JP2004536857A5 true JP2004536857A5 (https=) 2006-01-05

Family

ID=3830401

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003513564A Withdrawn JP2004536857A (ja) 2001-07-17 2002-07-16 癌の治療のための方法及び組成物

Country Status (10)

Country Link
US (1) US20040067952A1 (https=)
EP (1) EP1423118A4 (https=)
JP (1) JP2004536857A (https=)
KR (1) KR20040038984A (https=)
CN (1) CN1551771A (https=)
AU (1) AUPR644301A0 (https=)
BR (1) BR0211436A (https=)
CA (1) CA2453993A1 (https=)
MX (1) MXPA04000518A (https=)
WO (1) WO2003007957A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005222084B2 (en) * 2004-03-05 2010-04-22 Benitec, Inc. Multiple promoter expression cassettes for simultaneous delivery of RNAI agents
EP2200613B1 (en) 2007-09-21 2018-09-05 The Johns Hopkins University Phenazine derivatives and uses thereof
KR20140051555A (ko) * 2012-10-23 2014-05-02 씨지케이바이오 주식회사 전립선암 예방 및 치료용 약학 조성물
CN103360329B (zh) * 2013-07-18 2015-11-18 中国科学院南海海洋研究所 一类吩嗪化合物及其在制备抗肿瘤药物中的应用
CA2997671A1 (en) * 2015-10-06 2017-04-13 Redhill Biopharma Ltd. Combination therapies for treating cancer
WO2019060409A1 (en) * 2017-09-19 2019-03-28 The Cleveland Clinic Foundation INHIBITION OF CONNEXIN 46 TO TREAT A GLIOBLASTOMA AND OTHER STATES
CN119564691A (zh) * 2024-12-13 2025-03-07 首都医科大学附属北京佑安医院 氯法齐明在制备治疗癌症的药物中的应用
CN119700770A (zh) * 2025-01-09 2025-03-28 首都医科大学附属北京佑安医院 氯法齐明在制备修复肠黏膜或改善肠道菌群药物中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3658M (fr) * 1964-02-18 1965-11-02 Michel Marie Andre Guerbet Composition huileuse pour l'injection intravasculaire.
US4578391A (en) * 1982-01-20 1986-03-25 Yamanouchi Pharmaceutical Co., Ltd. Oily compositions of antitumor drugs
JPS6296A (ja) * 1985-03-06 1987-01-06 Sumitomo Pharmaceut Co Ltd 脂溶性白金（２）錯体
US5103018A (en) * 1986-08-26 1992-04-07 Kyowa Hakko Kogyo Kabushiki Kaisha Mitomycin derivatives
ZA928419B (en) * 1991-11-29 1994-03-01 Univ Pretoria Pharmaceutical substances or compositions and their use
DE69528103T2 (de) * 1994-04-05 2003-05-15 Universiteit Van Pretoria, Gauteng Verwendung von Riminophenazin zur Behandlung von MDR-Resistenz
US5763443A (en) * 1994-04-05 1998-06-09 Universiteit Van Pretoria MDR resistance treatment and novel pharmaceutically active riminophenazines
DE19843223A1 (de) * 1998-09-22 2000-03-30 Hassan Jomaa Phosphororganische Verbindungen und ihre Verwendung
AUPP332898A0 (en) * 1998-05-04 1998-05-28 Unisearch Limited Pharmaceutical composition

Similar Documents

Publication Publication Date Title
KR102008635B1 (ko) 영상화제의 합성 및 사용을 위한 조성물, 방법 및 시스템
JP2005500300A5 (https=)
JP2007511504A5 (https=)
JP2002540208A5 (https=)
JP2015512943A5 (https=)
RU2014115847A (ru) Пирролопиримидиновые соединения для лечения злокачественной опухоли
JP2009538336A5 (https=)
JP2009530392A5 (https=)
JP2004517843A5 (https=)
JP2004536857A5 (https=)
JP2007523177A5 (https=)
RU99101081A (ru) Режим введения ингибиторов н+, к+-атфазы
RU2002134754A (ru) Аналоги жирных кислот для лечения рака
CA2380022A1 (en) Aromatic esters of camptothecins and methods to treat cancers
RU2012114146A (ru) Нерадиоактивные фосфолипидные соединения, композиции и способы их применения
JP2009502777A5 (https=)
RU2020143060A (ru) Антагонисты рецепторов соматостатина и способы их применения
RU2010154417A (ru) Комбинация частичного агониста никотиновых рецепторов и ингибитора ацетилхолинетеразы, содержащая ее фармацетическая композиция, и ее применение в лечении когнитивных расстройств
JP2008528617A5 (https=)
RU2002105374A (ru) Сочетанная терапия с использованием пентафторбензолсульфонамидов
CA2596084A1 (en) Treatment of metastasized tumors with quinolinone benzimidazole compounds
US9376432B2 (en) Use of VEGFR-3 inhibitors for treating hepatocellular carcinoma
ES2898708T3 (es) Ligandos macrocíclicos lipófilos, sus complejos, así como sus usos médicos
US7067508B2 (en) Diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition
CA2599321A1 (en) Radioactive halogen-labeled phenyloxyaniline derivatives